Paediatric myelodysplasia

British Medical Bulletin

Volumn 52, Issue 4, 1996, Pages 778-786

  Passmore, S J ^a   Hann, I M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CHILDHOOD DISEASE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DOWN SYNDROME; EOSINOPHILIA; HISTOCOMPATIBILITY; HUMAN; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; REVIEW;

EID: 0030476577     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011582     Document Type: Review

References (29)

1. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-99
2. Hasle H, Kerndrup G. Epidemiology of MDS in childhood. Current Problems of Childhood. 1995
3. Passmore SJ, Hann IM, Stiller CA et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85: 1742-50
4. Savage DG, Goldman JM. Approaches to the treatment of chronic myeloid leukemia. Int J Hematol 1994; 60: 1-21
5. Hasle H. Myelodysplastic syndromes in childhood-classification, epidemiology and treatment. Leukemia Lymphoma 1994; 13: 11-26
6. Miller DR. Erythropoiesis, hypoplastic anaemias, and disorders of heme synthesis. In: Miller DR, Baehner RL, eds. Blood Diseases of Infancy and Childhood. St Louis: Mosby, 1995; 140-92
7. Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. A report of the Workshop held in Scottsdale, Arizona, February 23-25, 1987. Cancer Genet Cytogenet 1988; 32: 1
8. Freedman MH, Cohen A, Grunberger T et al. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia. Br J Haematol 1992; 80: 40-8
9. Herrod HG, Dow LW, Sullivan JL. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies. Blood 1983; 61: 1098-104
10. Freedman MH, Estrov Z, Chan HSL. Juvenile chronic myelogenous leukemia. Am J Pediatr Hematol Oncol 1988; 10: 261-7
11. Castleberry RP, Freedman MH, Baruchel A et al. Juvenile chronic myelogenous leukemia revisited. A report of the first meeting of the International Juvenile Myelomonocytic Leukemia Working Group (IJWG). Br J Haematol 1996; In press
12. Evans JPM, Czepulkowski B, Gibbons B, Swansbury GJ, Chessells JM. Childhood monosomy 7 revisited. Br J Haematol 1988; 69: 41-5
13. Sieff CA, Chessells JM, Harvey BAM, Pickthall VJ, Lawler SD. Monosomy 7 in childhood: a myeloproliferative disorder. Br J Haematol 1981; 49: 235-49
14. Butcher M, Frenck R, Emperor J et al. Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders. Genes Chromosom Cancer 1995; 12: 50-7
15. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79: 3101-9
16. Jani K, Kempski HM, Reeves BR. A case of myelodysplasia with eosinophilia having a translocation t(5;12)(q31;q13) restricted to myeloid cells but not involving eosinophils. Br J Haematol 1994; 87: 57-60
17. Hasle H, Jacobsen BB, Pedersen NT. Myelodysplastic syndromes in childhood: a population based study of nine cases. Br J Haematol 1992; 81: 495-8
18. Tuncer MA, Pagliuca A, Hicsonmez G, Yetgin S, Ozsoylu S, Mufti GJ. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases. Br J Haematol 1992; 82: 347-53
19. Hayani A, Mahoney DHJ, Taylor LD. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. J Neurooncol 1992; 14: 57-62
20. Luna-Fineman S, Shannon KM, Lange BJ. Childhood monosomy 7: epidemiology, biology and mechanistic implications. Blood 1995; 85: 1985-99
21. Bunin NJ, Casper JT, Lawton C et al. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. Bone Marrow Transplant 1992; 9: 119-22
22. Donadieu J, Stephan JL, Blanche S et al. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 777-82
23. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677-81
24. Sanders JE, Buckner CD, Thomas ED et al. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 1988; 71: 1144-6
25. Castleberry RP, Emanuel PD, Zuckerman KS et al. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukaemia. N Engl J Med 1994; 331:
26. Festa RS, Shende A, Lanzkowsky P. Juvenile chronic myelocytic leukemia: experience with intensive combination chemotherapy. Med Pediatr Oncol 1990; 18: 311-6
27. Castro-Malaspina H, Schaison G, Passe S et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer 1984; 54: 675-86
28. Randall DL, Reiquam CW, Githens JH, Robinson A. Familial myeloproliferative disease. Am J Dis Child 1965; 110: 479-90
29. Bain B. Down's syndrome-transient abnormal myelopoiesis and acute leukaemia. Leukemia Lymphoma 1991; 3: 309-17